Augmentation of myocardial transfection using TerplexDNA: a novel gene delivery system
Authors:
- L YuLYL Yu
- DA BullDBDA Bull
- Sh BaileySBSh Bailey
- Sw KimSKSw Kim
- 1 March 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (5) , 349-353
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 12 references indexed in Scilit:
- Viral vectors for gene delivery and gene therapy within the endocrine systemJournal of Endocrinology, 2000
- Intramyocardial Gene Therapy with Naked DNA Encoding Vascular Endothelial Growth Factor Improves Collateral Flow to Ischemic MyocardiumHuman Gene Therapy, 1999
- Taking polycation gene delivery systems from in vitro to in vivoPharmaceutical Science & Technology Today, 1999
- Viral Vectors for Gene TherapyPharmacology & Therapeutics, 1998
- Gene Transfer Technology in Therapy: Current Applications and Future GoalsThe Oncologist, 1998
- A new non-viral DNA delivery vector: the terplex systemJournal of Controlled Release, 1998
- Terplex DNA Delivery System As a Gene CarrierPharmaceutical Research, 1998
- Vector development: a major obstacle in human gene therapy.Annals of Medicine, 1998
- An endothelial receptor for oxidized low-density lipoproteinNature, 1997
- Focal accumulation of an apolipoprotein B-based synthetic oligopeptide in the healing rabbit arterial wall.Proceedings of the National Academy of Sciences, 1990